Title	Publication Date	Language	Citations
Seeing the good and bad in aplastic anemia: is autoimmunity in AA dysregulated or antineoplastic?	2002/01/01		9
The myelodysplastic syndromes: analysis of prognostic factors and comparison of prognostic systems in 128 Chinese patients from a single institution	2002/01/01		9
Prolonged administration of all-trans retinoic acid in combination with intensive chemotherapy and G-CSF for adult acute myelogenous leukemia: single-centre pilot study in different risk groups	2002/01/01		8
Enhancement of erythropoietin-stimulated cell proliferation by Anandamide correlates with increased activation of the mitogen-activated protein kinases ERK1 and ERK2	2000/01/01		8
Ethical and legal aspects of placental/cord blood banking and transplant	2000/01/01		8
MEK–ERK pathway is expressed but not activated in high proliferating, self-renewing cord blood hematopoietic progenitors	2002/01/01		8
Recent developments in the understanding of iron metabolism	2002/01/01		8
Role of plasminogen activators and urokinase receptor in platelet kinetics	2000/01/01		8
Do anthracyclines have a role in the therapy of multiple myeloma?	2000/01/01		7
Factor XIII Val34Leu polymorphism in primary intracerebral haemorrhage	2000/01/01		7
STAT3β does not interfere with granulocyte colony-stimulating factor-induced neutrophilic differentiation	2000/01/01		6
Hemoglobin induces the expression and secretion of vascular endothelial growth factor from human malignant cells	2002/01/01		6
A mouse model for immunotherapy of myeloma	2002/01/01		5
Acute leukemia following a previous malignancy: do acute lymphoid leukemia and acute myeloid leukemia have common risk factors?	2000/01/01		5
14q32 chromosomal translocations: a hallmark of plasma cell dyscrasias?	2000/01/01		5
The utility of the zinc-protoporphyrin assay as an initial screen for iron-deficient erythropoiesis	2002/01/01		4
Prognostic relevance of a scoring system based on clinical and biological parameters in early chronic lymphocytic leukemia	2000/01/01		4
Choice of replacement therapy for hemophilia: recombinant products only?	2000/01/01		4
Is escalated BEACOPP a standard therapy for advanced Hodgkin's disease?	2000/01/01		4
Genetic alterations underlying the pathogenesis of MALT lymphoma	2002/01/01		4
E2A/HLF fusion gene in an acute lymphoblastic leukemia patient with disseminated intravascular coagulation and a normal karyotype	2002/01/01		4
Radiation therapy in early stage Hodgkin's disease: long-term results and adverse effects	2002/01/01		4
Immune reconstitution during intensive chemotherapy in patients with human immunodeficiency virus related non-Hodgkin lymphoma	2002/01/01		3
Phase I trials in cancer treatment. The maximum tolerated dose: A barbarian guideline	2000/01/01		3
Treatment of Langerhans cell histiocytosis with 2′-deoxycoformycin(2′-DCF)	2002/01/01		3
V-region-specific alterations of serum IgM production in multiple myeloma of IgG class	2000/01/01		3
Is the scoring system an effective clinico-biological tool in myeloid antigen positive adult acute lymphoblastic leukemia? Results of a long-term study	2002/01/01		3
Acute myelogenous leukaemia in older patients at St Bartholomew's Hospital: outcome with mitoxantrone and cytarabine	2002/01/01		2
Editorial	2000/01/01		2
Interleukin-6 stimulates HHV-8 replication in bone marrow cultures and infected cell lines	2000/01/01		2